The recent finding that gRV integration is mediated by binding to BET revealed a compelling link to cancer, as BET binding to acetylated histones is one of the defining feature of ‘super-enhancers’, a term coined to describe large clusters of enhancers that display dense binding of master regulators and play a role in tissue-specific cell identity [25]. Here, DNER is linked to cancer.